A Positive Commitment from Cubist: A Review of DIFICID® (fidaxomicin) and SIVEXTRO™ (tedizolid phosphate) (Not Official IDWeek Programming - Supported by Cubist - See Affiliated Event Guide for More Information)
All Satellite Symposia, Presentation Theaters, and Learning Lounges preceding and following the Official Program IDWeekTM 2014 are independently organized and executed. IDWeek does not endorse or support the programming of any Symposium, Presentation Theater or Learning Lounge.
Amar Safdar, MD
Director, Transplant Infectious Diseases
The NYU School of Medicine, Langone Medical Center
New York, NY
The presentation will focus on the epidemiology and burden of Clostridium difficile-associated diarrhea (CDAD). Important management strategies using DIFICID® (fidaxomicin) tablets for patients ≥ 18 years of age with CDAD, as well as physician and patient resources, will also be presented.